ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
L00-L99: Diseases of the skin and subcutaneous tissue |
Acne vulgaris |
L70.0 |
MMP2 |
I00-I99: Diseases of the circulatory system |
Angiogenesis disorder |
I00-I99 |
KDR |
C00-D49: Neoplasms |
Solid tumours |
C00-D48 |
CA9; MMP9; MMP2; KDR; KDR; KDR; AURKB; AURKA |
I00-I99: Diseases of the circulatory system |
Aortic aneurysm |
I71 |
MMP12 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Pruritus |
L29 |
PLA2G1B |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
MMP12; PLA2G1B |
I00-I99: Diseases of the circulatory system |
Arteriosclerosis |
I70 |
PLA2G1B |
I00-I99: Diseases of the circulatory system |
Atherosclerosis |
I70 |
HSD11B1; MMP12 |
C00-D49: Neoplasms |
Myelodysplastic syndrome |
D46 |
KDR |
C00-D49: Neoplasms |
Metastatic colorectal cancer |
C18-C21 |
KDR |
NA: NA |
Colour dead tissues |
NA |
PTPN1 |
C00-D49: Neoplasms |
Colorectal cancer |
C18-C21 |
MMP9; KDR |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic syndrome x |
E88.81 |
HSD11B1 |
C00-D49: Neoplasms |
Hematological malignancies |
C81-C86 |
AURKB |
C00-D49: Neoplasms |
Non-small cell lung cancer |
C33-C34 |
KDR |
C00-D49: Neoplasms |
Non-small-cell lung cancer |
NA |
KDR |
E00-E89: Endocrine, nutritional and metabolic diseases |
Non-insulin dependent diabetes |
E11.9 |
HSD11B1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
PTPN1; HSD11B1 |
C00-D49: Neoplasms |
Squamous cell cancer of head and neck |
NA |
KDR |
A00-B99: Certain infectious and parasitic diseases |
Leishmaniasis |
B55.0 |
PLA2G1B |
C00-D49: Neoplasms |
Head and neck cancer |
C07-C14, C32-C33 |
KDR; KDR |
C00-D49: Neoplasms |
Renal cell carcinoma |
NA |
MMP2; KDR; KDR |
C00-D49: Neoplasms |
Renal cancer |
C64 |
CA9; KDR |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
PTPN1; PTPN1; GPBAR1; HSD11B1; NFKB1 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Allergy |
T78.4 |
PLA2G1B |
A00-B99: Certain infectious and parasitic diseases |
Infections |
A00-B99 |
PTPN1 |
C00-D49: Neoplasms |
Late-stage solid tumors |
C00-C75, C7A, C7B, D10-D36, D3A |
AURKA |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anxiety disorder |
F32, F40-F42 |
OPRD1 |
I00-I99: Diseases of the circulatory system |
Ischemic heart diseases |
I20-I25 |
OPRD1 |
H00-H59: Diseases of the eye and adnexa |
Ocular hypertension |
H40.0 |
HSD11B1 |
H00-H59: Diseases of the eye and adnexa |
Open-angle glaucoma |
H40-H42 |
CA2 |
C00-D49: Neoplasms |
Fallopian tube cancer |
C57.0, D28.2 |
KDR |
C00-D49: Neoplasms |
Pancreatic cancer |
C25 |
MMP2; KDR |
C00-D49: Neoplasms |
Metastatic breast cancer |
C50 |
KDR |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
GPBAR1; HSD11B1 |
C00-D49: Neoplasms |
Metastatic castration-resistant prostate cancer |
C61 |
KDR |
C00-D49: Neoplasms |
Gastric cancer |
C16 |
KDR; KDR |
C00-D49: Neoplasms |
Overactive bladder disorder |
C67, N32.81 |
OPRD1 |
C00-D49: Neoplasms |
Ovarian cancer |
C56 |
MMP2; KDR; KDR; KDR; KDR |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Nerve injury |
T14.4 |
PLA2G1B |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Premature ejaculation |
F52.4 |
OPRD1 |
I00-I99: Diseases of the circulatory system |
Stroke |
I61-I63, I80-I82 |
MMP9 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Major depressive disorder |
F32, F33, M32 |
OPRD1 |
C00-D49: Neoplasms |
Peritoneal cavity cancer |
NA |
KDR |
C00-D49: Neoplasms |
Thyroid cancer |
C73 |
KDR |
C00-D49: Neoplasms |
Medullary thyroid cancer |
C73 |
KDR |
N00-N99: Diseases of the genitourinary system |
Bladder disease |
N30-N32 |
OPRD1 |
NA: NA |
Chronic diarrhea associated with inflammatory bowel disease |
NA |
OPRD1 |
H00-H59: Diseases of the eye and adnexa |
Chronic glaucoma |
H40-H42 |
CA1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Osteoarthritis |
M15-M19, M47 |
MMP2 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Lipid metabolism disorder |
E75-E78 |
HSD11B1 |
C00-D49: Neoplasms |
Liver cancer |
C22 |
KDR |
G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
OPRD1 |
C00-D49: Neoplasms |
Haematological malignancies |
C81-C86 |
AURKA |
C00-D49: Neoplasms |
Lung cancer |
C33-C34 |
MMP2 |
C00-D49: Neoplasms |
Lymphoma |
C81-C86 |
CA9 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Moderate-to-severe pain |
R52, G89 |
OPRD1 |
C00-D49: Neoplasms |
Clear cell renal cell carcinoma |
C64 |
CA9 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses |
L20-L30 |
PLA2G1B |
L00-L99: Diseases of the skin and subcutaneous tissue |
Inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp |
L20-L30 |
PLA2G1B |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
MMP12; PLA2G1B |
J00-J99: Diseases of the respiratory system |
Influenza virus |
J11.1 |
HSD11B1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Arthritis |
M00-M25 |
MMP1; PLA2G1B |
J00-J99: Diseases of the respiratory system |
Chronic obstructive pulmonary disease |
J40-J44, J47 |
MMP12; MMP12 |
C00-D49: Neoplasms |
Gastrointestinal cancers |
C15-C26 |
KDR |
C00-D49: Neoplasms |
Breast cancer |
C50 |
CA9; KDR; KDR; KDR |
C00-D49: Neoplasms |
Cutaneous Melanoma |
C43-C44 |
KDR |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Cough |
R05 |
OPRD1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
PTPN1; HSD11B1; HSD11B1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Contact dermatitis |
L23, L24, L25 |
PLA2G1B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Hypercholesterolemia |
E78 |
HSD11B1 |
C00-D49: Neoplasms |
Glioma |
C71 |
KDR |
H00-H59: Diseases of the eye and adnexa |
Glaucoma |
H40-H42 |
CA1; CA1 |
NA: NA |
Acute nonspecific diarrhea |
NA |
OPRD1 |
G00-G99: Diseases of the nervous system G00-G99 |
Acute migraine |
G43 |
OPRD1 |
C00-D49: Neoplasms |
Acute myeloid leukemia |
C92.0 |
AURKB; AURKA |
I00-I99: Diseases of the circulatory system |
Cardiovascular disorder |
I00-I99 |
KDR |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic nephropathy |
E11.21 |
MMP1 |
I00-I99: Diseases of the circulatory system |
High blood pressure |
I10-I16 |
CA2 |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
CA1; CDC25B; CA9; MMP9; NFKB1; MMP2; KDR; AURKA |
K00-K95: Diseases of the digestive system |
Diarrhea-predominant IBS |
K58.0 |
OPRD1 |
C00-D49: Neoplasms |
Hepatocellular carcinoma |
C22.0 |
KDR |
C00-D49: Neoplasms |
Advanced malignancies |
C00-C96 |
KDR |
C00-D49: Neoplasms |
Advanced renal cell carcinoma |
C64 |
KDR; KDR |
C00-D49: Neoplasms |
Biliary cancer |
C22, C24 |
KDR |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
OPRD1; MMP1; PLA2G1B |
K00-K95: Diseases of the digestive system |
Duodenal ulcers |
K25-K27 |
CA2; CA1 |
A00-B99: Certain infectious and parasitic diseases |
Visceral leishmaniasis |
B55.0 |
PLA2G1B |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Insomnia |
F51.0, G47.0 |
CA2 |
C00-D49: Neoplasms |
Advanced solid tumor |
C00-C75, C7A, C7B |
AURKA |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Alcohol use disorders |
F10.2 |
OPRD1 |
NA: NA |
Edema |
NA |
CA2 |
I00-I99: Diseases of the circulatory system |
Edema associated with congestive heart failure |
I50, R60.9 |
CA2 |
C00-D49: Neoplasms |
AML |
NA |
KDR |
J00-J99: Diseases of the respiratory system |
Allergic rhinitis |
J00, J30, J31.0, T78.4 |
PLA2G1B |
C00-D49: Neoplasms |
Melanoma |
C43 |
KDR; KDR |
K00-K95: Diseases of the digestive system |
Ulcerative colitis |
K51 |
MMP9 |
N00-N99: Diseases of the genitourinary system |
Urinary incontinence |
N39.3, N39.4, R32 |
OPRD1 |